查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586116

心臟生物标记诊断试剂套件市场：按疾病、测试、产品和最终用户 - 2025-2030 年全球预测

Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

心臟生物标记诊断试剂套件市场2023年估值为37.8亿美元，预计到2024年将达到41.1亿美元，复合年增长率为8.93%，到2030年将达到68.8亿美元。 。

心臟生物标记诊断套件的范围包括透过肌钙蛋白、CK-MB 和 BNP 等生物标记物检测和管理心血管疾病。这些套件提供了有关心肌梗塞、心臟衰竭和其他心臟疾病的重要资料，对于心臟病的及时诊断和监测至关重要。这些套件广泛应用于医院、诊所和研究机构，为病患管理提供了宝贵的见解。由于急诊和就地检验环境的需求迅速增加，最终用途领域正在扩大。心血管疾病盛行率的上升、早期诊断意识的提高以及能够灵敏和特异性检测心臟生物标记的技术进步对市场成长产生了重大影响。此外，老化和生活方式的改变也是成长要素。可携式诊断设备和个人化医疗方法的进步带来了巨大的机会。自动化、高精度的就地检验套件的创新可以抓住这些机会，开拓服务不足的市场，并提高可及性。然而，市场面临挑战，例如与先进检测套组相关的高成本以及可能延迟产品发布的严格监管要求。此外，与传统诊断方法存在竞争，这可能会对新的进入造成障碍。整合人工智慧进行预测分析的经济高效套件的开发研究和创新代表了一个肥沃的成长领域。鼓励探索生物技术公司和医疗保健提供者之间的合作，以促进采用和创新。由于产业内不断的产品创新和整合，市场竞争激烈且充满活力。为了实现永续成长，保持灵活的策略方法来应对不同地区的监管环境，同时注重研发投资，将提供竞争优势和市场领先地位，这是最重要的保证。

主要市场统计
基准年[2023] 37.8亿美元
预测年份 [2024] 41.1亿美元
预测年份 [2030] 68.8亿美元
复合年增长率（%） 8.93%

市场动态：快速发展的心臟生物标记诊断试剂套件市场的关键市场洞察

供需的动态交互作用正在改变心臟生物标记诊断试剂套件市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球心血管疾病患者数量增加
    • 老年人口的增加以及随之而来的慢性病负担的增加
    • 消费者对早期诊断和早期治疗的偏好不断增加
  • 市场限制因素
    • 对样本采集和储存的担忧
  • 市场机会
    • 加大研发力度，开发新开发
    • 就地检验(POCT) 的成长趋势
  • 市场挑战
    • 缺乏保险报销政策

波特五力：引领心臟生物标记诊断试剂套件市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟生物标记诊断试剂套件市场的外部影响

外部宏观环境因素在塑造心臟生物标记诊断试剂套件市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟生物标记诊断试剂套件市场的竞争状况

心臟生物标记诊断套件市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵心臟生物标记诊断试剂套件市场供应商的绩效评估

FPNV定位矩阵是评估心臟生物标记诊断试剂套件市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心臟生物标记诊断试剂套件市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对心臟生物标记诊断试剂套件市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病在世界范围内呈上升趋势
      • 人口老化加剧以及随之而来的慢性病负担的增加
      • 消费者越来越寻求早期诊断和治疗
    • 抑制因素
      • 对样本采集和储存的担忧
    • 机会
      • 加大研发力度，实现新开发
      • 就地检验(POCT) 的成长趋势
    • 任务
      • 缺乏支持性报销政策
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心臟生物标记诊断试剂套件市场：依疾病分类

  • 心绞痛
  • 心臟衰竭
  • 心肌梗塞

第七章心臟生物标记诊断试剂套件市场测试

  • 临床检查
  • 就地检验

第八章心臟生物标记诊断试剂套件市场：按产品

  • BNP检测套组
  • C反应蛋白
  • CK-MB检测试剂套件
  • 肌红蛋白检测套组
  • 肌钙蛋白检测套组

第九章心臟生物标记诊断试剂套件市场：依最终用户分类

  • 诊所
  • 诊断中心
  • 医院

第十章北美和南美心臟生物标记诊断试剂套件市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区心臟生物标记诊断试剂套件市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲心臟生物标记诊断试剂套件市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Atlas Medical GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Creative Diagnostics
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LSI Medience Corporation
  • MP Biomedicals, LLC
  • PerkinElmer, Inc.
  • Randox Laboratories Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-433AB1DC288A

The Cardiac Biomarker Diagnostic Kits Market was valued at USD 3.78 billion in 2023, expected to reach USD 4.11 billion in 2024, and is projected to grow at a CAGR of 8.93%, to USD 6.88 billion by 2030.

The scope of cardiac biomarker diagnostic kits encompasses the detection and management of cardiovascular diseases through biomarkers like Troponins, CK-MB, BNP, and others. These kits are essential for timely diagnosis and monitoring of heart conditions, offering crucial data on myocardial infarction, heart failure, and other cardiac events. They find extensive application in hospitals, clinics, and research institutes, providing valuable insights for patient management. The end-use landscape is expanding with a demand surge in emergency care settings and point-of-care testing environments. Market growth is significantly influenced by the rising prevalence of cardiovascular diseases, increased awareness about early diagnostics, and technological advancements that enable highly sensitive and specific detection of cardiac biomarkers. Furthermore, the aging population and lifestyle changes are contributory growth factors. Notable opportunities arise from advancements in portable diagnostic devices and personalized medicine approaches. Innovating in automated and highly accurate point-of-care testing kits can seize these opportunities, tapping into underserved markets and enhancing accessibility. However, the market faces challenges such as high costs associated with advanced testing kits and stringent regulatory requirements that may delay product launches. Moreover, there exists competition from traditional diagnostic methods, which can be a barrier for new entrants. Research and innovation in developing cost-effective kits with integrated artificial intelligence for predictive analytics represent fertile areas for growth. Exploring collaborations between biotech companies and healthcare providers is recommended to drive adoption and innovation. The market is highly competitive and dynamic, driven by continuous product innovation and mergers within the industry. For sustainable growth, maintaining a flexible yet strategic approach to navigate regulatory landscapes, across different regions, while emphasizing R&D investments, will be paramount in ensuring competitive advantage and market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 3.78 billion
Estimated Year [2024] USD 4.11 billion
Forecast Year [2030] USD 6.88 billion
CAGR (%) 8.93%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Biomarker Diagnostic Kits Market

The Cardiac Biomarker Diagnostic Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of cardiovascular diseases worldwide
    • Rising geriatric population and the consequent increase in the burden of chronic diseases
    • Growing consumer preference for early diagnosis and treatment
  • Market Restraints
    • Concerns related to sample collection and storage
  • Market Opportunities
    • Increase in R&D efforts for new developments
    • Growing trend of Point-of-care testing (POCT)
  • Market Challenges
    • Lack of supportive reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Biomarker Diagnostic Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Biomarker Diagnostic Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Biomarker Diagnostic Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Biomarker Diagnostic Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Biomarker Diagnostic Kits Market

A detailed market share analysis in the Cardiac Biomarker Diagnostic Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Biomarker Diagnostic Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Biomarker Diagnostic Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Biomarker Diagnostic Kits Market

A strategic analysis of the Cardiac Biomarker Diagnostic Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Biomarker Diagnostic Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Atlas Medical GmbH, Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Creative Diagnostics, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., LSI Medience Corporation, MP Biomedicals, LLC, PerkinElmer, Inc., Randox Laboratories Ltd., Siemens Healthcare GmbH, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiac Biomarker Diagnostic Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease, market is studied across Angina Pectoris, Cardiac Heart Failure, and Myocardial Infraction.
  • Based on Testing, market is studied across Laboratory Testing and Point of Care Testing.
  • Based on Product, market is studied across BNP Test Kit, C-Reactive Protein, CK-MB Test Kits, Myoglobin Test Kits, and Troponin Test Kits.
  • Based on End-User, market is studied across Clinics, Diagnostics Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of cardiovascular diseases worldwide
      • 5.1.1.2. Rising geriatric population and the consequent increase in the burden of chronic diseases
      • 5.1.1.3. Growing consumer preference for early diagnosis and treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to sample collection and storage
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in R&D efforts for new developments
      • 5.1.3.2. Growing trend of Point-of-care testing (POCT)
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of supportive reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Biomarker Diagnostic Kits Market, by Disease

  • 6.1. Introduction
  • 6.2. Angina Pectoris
  • 6.3. Cardiac Heart Failure
  • 6.4. Myocardial Infraction

7. Cardiac Biomarker Diagnostic Kits Market, by Testing

  • 7.1. Introduction
  • 7.2. Laboratory Testing
  • 7.3. Point of Care Testing

8. Cardiac Biomarker Diagnostic Kits Market, by Product

  • 8.1. Introduction
  • 8.2. BNP Test Kit
  • 8.3. C-Reactive Protein
  • 8.4. CK-MB Test Kits
  • 8.5. Myoglobin Test Kits
  • 8.6. Troponin Test Kits

9. Cardiac Biomarker Diagnostic Kits Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostics Centers
  • 9.4. Hospitals

10. Americas Cardiac Biomarker Diagnostic Kits Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Biomarker Diagnostic Kits Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Biomarker Diagnostic Kits Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Atlas Medical GmbH
  • 3. Beckman Coulter, Inc.
  • 4. Becton, Dickinson, and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Creative Diagnostics
  • 8. DiaSorin S.p.A.
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Guangzhou Wondfo Biotech Co., Ltd.
  • 11. Lepu Medical Technology (Beijing) Co., Ltd.
  • 12. LSI Medience Corporation
  • 13. MP Biomedicals, LLC
  • 14. PerkinElmer, Inc.
  • 15. Randox Laboratories Ltd.
  • 16. Siemens Healthcare GmbH
  • 17. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFRACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BNP TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CK-MB TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TROPONIN TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2023